| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.56B | +23.9% |
| Gross profit | ¥0.13B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.06B | +2.4% |
| Gross margin | 24.3% | Net margin 10.7% |
| Revenue Q/Q | +24.8% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.42B | 75.7% |
| R&D | ¥0.02B | 3.5% |
| SG&A | ¥0.03B | 5.9% |
| Tax & other | ¥0.01B | 2.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
科源制药 ・ 金禄电子 ・ 聚胶股份 ・ 鸿日达 ・ 侨源股份 ・ 康力源 ・ 清研环境 ・ 国缆检测 ・ 东星医疗 ・ 明阳电气 ・ 海科新源 ・ 三博脑科
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies